Official resources and media assets for coverage of SmartCemic and NorCemic Inc.
NorCemic Inc. is a pioneering medical technology company headquartered in Phoenix, Arizona, focused on non-invasive health tracking. Our flagship product, SmartCemic, uses our proprietary quantum-enhanced analysis platform to track 114+ biomarkers without blood draws or invasive procedures. The company was founded in 2022 with a mission to democratize comprehensive health tracking.
To advance personal health tracking by making comprehensive biomarker analysis accessible, painless, and continuous for everyone, enabling individuals to understand their health through our quantum-enhanced platform.
SmartCemic is a non-invasive wellness device that tracks biomarkers without needles, strips or lancets. Readings sync to the SmartCemic app, where users can view trends over time and export a summary to share with their clinician. The device is calibrated across the full ten-point Monk Skin Tone Scale so readings stay consistent across users.
PNG, SVG, EPS formats in various sizes
Colors, typography, usage rules
High-resolution product images
Key facts, specs, and figures
NorCemic Inc. submitted a Breakthrough Device Designation (BDD) Request to the FDA Center for Devices and Radiological Health for SmartCemic, under the 21st Century Cures Act.
NorCemic Inc. announces SmartCemic, a non-invasive wellness device designed to track over 114 biomarkers including glucose, ketones, hydration and metabolic panels, without needles or blood draws.
NorCemic Inc. launches SmartCemic wellness platform, bringing quantum-enhanced health tracking technology to fitness enthusiasts and health-conscious consumers.
NorCemic Inc. files US patent application for its proprietary Quantum-Enhanced Spectral Analysis (QESA) technology, protecting key innovations in non-invasive biomarker detection.
For press inquiries, interviews, product reviews, or additional information, please contact our media relations team:
admin@norcemic.com